4 Sep 2024 Date | | - Cons. EPS | - EPS |
30 Aug 2024 Date | | - Cons. EPS | - EPS |
30 Jun 2016 Date | | - Cons. EPS | 0 EPS |
31 Mar 2016 Date | | - Cons. EPS | 0 EPS |
30 Jun 2015 Date | | - Cons. EPS | 0 EPS |
4 Sep 2024 Date | | - Cons. EPS | - EPS |
30 Aug 2024 Date | | - Cons. EPS | - EPS |
30 Jun 2016 Date | | - Cons. EPS | 0 EPS |
31 Mar 2016 Date | | - Cons. EPS | 0 EPS |
30 Jun 2015 Date | | - Cons. EPS | 0 EPS |
Medical - Care Facilities Industry | Healthcare Sector | Mr. Shawn Siu CEO | OTC PINK Exchange | HK0000264595 ISIN |
CN Country | 829 Employees | - Last Dividend | - Last Split | - IPO Date |
China Evergrande New Energy Vehicle Group Limited stands as a pivotal entity in the realm of new energy vehicles, embedding itself in the fabric of technology research, development, manufacturing, and sales on a global scale. Initially launched in 1999 and originally named Evergrande Health Industry Group Limited, the company pivoted to its current nomenclature in August 2020 to more accurately reflect its evolved focus on new energy vehicles. With its headquarters stationed in Guangzhou, People's Republic of China, Evergrande NEV operates under the corporate umbrella of China Evergrande Group, signifying a substantial backing and integration within the larger conglomerate’s vast network. Their operational spectrum spans across critical markets in the People's Republic of China and extends to Europe and other international regions, signifying the global ambition and reach of the company. Evergrande NEV’s business ventures encapsulate a diversified range of products and services from the sale of living projects to sophisticated smart mobility solutions, furthering the development of power lithium-ion batteries and electric vehicles. This multifaceted approach not only reinforces their commitment to innovation within the new energy vehicle sector but also captures a broader mission to revolutionize mobility, healthcare, and home care solutions for a more sustainable future.